Health
High Dose Favipiravir Countered SARS-CoV-2 in Hamsters, Hydroxychloroquine Ineffective – Global Biodefense
Virologists at the Rega Institute have shown that the anti-malaria drug hydroxychloroquine does not limit SARS-CoV-2 coronavirus replication in hamsters.
Virologists at the Rega Institute have shown that the anti-malaria drug hydroxychloroquine does not limit SARS-CoV-2 coronavirus replication in hamsters. A high dose of the anti-flu drug favipiravir, by contrast, has an antiviral effect in the hamsters. The team published their findings in this week in the Proceedings of the National Academy of Sciences (PNAS).
Virologists at the KU Leuven Rega Institute have been working on two lines of SARS-CoV-2 research: searching for a vaccine to prevent …
-
General15 hours agoQantas terminal at Melbourne Airport evacuated and flights delayed due to fire
-
Noosa News24 hours agoJane Edmanson hangs up her Gardening Australia hat, reflects on labour of love behind show’s success
-
Noosa News24 hours agoA Boutique Journey Through Botswana and Zimbabwe
-
General23 hours agoFrench prisoners escape jail using saw and bedsheets